Searched for
CARDIAC DRUG
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Trump declares himself in 'perfect' health, as 80th birthday loomsDonald Trump said an annual medical checkup had gone "perfectly" Tuesday, as the health of the oldest US president ever to take the oath fa...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Make US (ballrooms) safer from gunsThe shocking attempted assassination of a U.S. President has thrown a glaring spotlight on America’s deep-rooted gun culture. Even in the f...
- Alkem Labs CEO Vikas Gupta may exit companyAlkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...
- Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 croreQuadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...
- Cardiac drugs log highest sales in 2025 as NCD cases surgeHeart medicines led sales in 2025, a trend set to continue. Respiratory and anti-diabetes drugs followed. Cardiac drug sales grew 13%, with...
- Heart of the matter: Sales of cardiac drugs beat strongerHeart disease is increasing in India. This is boosting sales of cardiac drugs. Sales have risen nearly 50% in five years. Younger people ar...
- India's most purchased drugs in the last decade are for cardiac ailments, diabetesAt around Rs 21,000 crore annually, cardiac medication forms the biggest therapy of drugs being bought by Indians today. A decade ago, it w...
- Drug sales reveal our lifestyle woesIndians spent over Rs 1,36,000 cr on medicines in last one year ending September 2019. People spent over Rs 17,000 cr on cardiac drugs, aro...
- Dishman in pact with European MNC for cardiac drugAhmedabad-based Dishman Pharmaceuticals will manufacture cardiac drug ingredients for a European multinational under a $50-million deal.
- Wockhardt gets US FDA approval for generic version of ToprolXLPharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for...
- Product recall may spell trouble for Sun Pharma's US arm reviewOne of the products recall in the world’s largest drug market by the US arm of Sun Pharma, India’s largest drugmaker by market capitalisati...
- Drug recall to have minimal impact on SunIndia’s largest drugmaker by market capitalisation Sun Pharma whose US arm recalled one of the products sold in the world’s largest drug ma...
Load More
